Baird Capital Invests in Blue Matter Consulting

Blue Matter Acquires Sam Brown Inc.

September 18, 2024

Healthcare Services

Blue Matter, a life-sciences consulting firm and portfolio company of Baird Capital, has acquired Sam Brown Inc., a healthcare-focused corporate communications and public relations agency. The acquisition will add full-service strategic communications capabilities (creative, digital and media) to Blue Matter’s consulting offerings; Sam Brown will retain its name and be led by founder Laura Liotta, who will join Blue Matter’s executive team.

Baird Capital Makes Minority Investment in JMAN Group

June 1, 2023

Data & Analytics

Baird Capital's Global Private Equity Fund made a minority investment in JMAN Group to support the data consultancy's international growth and expansion of its data-led solutions, with a specific focus on North America. Financial terms were not disclosed.

Baird Capital Invests in Azzur Group

April 26, 2021

Healthcare Services

Baird Capital’s private equity team has made a growth investment in Azzur Group to accelerate expansion of the company’s early‑phase life science services, including Azzur Cleanrooms on Demand. Financial terms were not disclosed; Baird Capital advisors Brett Tucker and Dave Schroeder joined Azzur’s board and Gary Knight joined as an independent director. Brown Gibbons Lang & Company served as Azzur’s financial advisor and Edgemont Partners advised Baird Capital.

Baird Capital Invests in Upfront Healthcare

November 17, 2020

Healthcare Services

Baird Capital has made a growth capital investment in Upfront Healthcare, a Chicago-based omnichannel patient engagement and communication platform founded in 2016. The investment is intended to support Upfront's continued growth and capability expansion to help health systems improve patient engagement and care delivery.

Baird Capital and Syndicate Invest in GreenLight Biosciences

January 8, 2019

Biotechnology

Baird Capital invested in GreenLight Biosciences as part of a $50 million funding round led by S2G Ventures to scale the company's RNA production platform for agricultural and life-science applications. The capital will support expansion of GreenLight's scalable, low-cost RNA manufacturing capabilities and enable entry/expansion into pharmaceutical and crop-protection markets.

Baird Capital Invests in HSP Group

December 3, 2020

Professional Services

Baird Capital has made a growth investment in HSP Group, a technology-enabled business services firm that provides finance, tax, legal and HR support to companies expanding internationally. The capital will help HSP Group launch and accelerate its operations and expand its service offerings across the US and Europe.